Ideal booking: before 10 weeks gestation. Facilitates early risk stratification, timely screening, and appropriate care pathway allocation.
Timing & First Contact
- Ideal: before 10 weeks gestation
- Offer by 8–10 weeks; latest acceptable: 12 weeks
- Late bookers (>20 weeks): accelerated pathway
- Confirm pregnancy with BHCG / USS if uncertain dates
- Establish gestational age: LMP + USS concordance
- Book dating scan if not yet done (11–13+6 weeks)
Folic Acid & Vitamins
- Folic acid 400 mcg daily — ideally before conception and up to 12 weeks
- High-dose folic acid 5 mg: diabetes, BMI >30, epilepsy on antifolates, previous NTD pregnancy
- Vitamin D 10 mcg (400 IU) daily throughout pregnancy — universal in GCC (indoor lifestyle/covered clothing)
- Iron: prescribe if Hb <11 g/dL
- Iodine supplementation: discuss (deficiency common in GCC)
Comprehensive History Taking
Obstetric History
- Gravida/parity/para notation
- Previous delivery mode (SVD/CS/instrumental)
- Previous CS: type of uterine incision, indication, interval
- PPH, retained placenta, blood transfusion
- Previous preterm birth (<37 weeks)
- Previous pre-eclampsia or GDM
- Previous stillbirth / neonatal death
- Previous fetal anomaly or chromosomal condition
- Assisted conception (IVF/ICSI)
Medical & Family History
- Hypertension, diabetes, thyroid disease
- Autoimmune: SLE, APS (antiphospholipid)
- Cardiac disease (congenital/acquired)
- Renal disease, epilepsy, thromboembolism
- Mental health: depression, anxiety, bipolar
- Family history: chromosomal, haemoglobinopathy, consanguinity
- Genetic conditions in first-degree relatives
Gynaecological & Social History
- Last smear result / HPV status
- Fibroids, ovarian cysts, uterine anomalies
- STI history, PID, infertility treatment
- Medications (prescribed and OTC) — teratogen review
- Allergies (drug/food/latex)
- Occupation (shift work, hazardous exposures)
- Smoking (AUDIT-C/CO breath test), alcohol (AUDIT), recreational drugs
- Social support network, housing
Physical Examination at Booking
- Blood pressure: seated, rested 5 min, correct cuff size, both arms first visit
- Height & weight: calculate BMI (kg/m²)
- BMI <18.5: nutritional support | BMI >30: enhanced monitoring, GDM risk
- Urinalysis: protein/glucose/leucocytes/nitrites (urine dipstick)
- Abdominal examination: fundal height after 20 weeks
- Breast examination: optional; offer if woman requests
- Pelvic examination: not routinely at booking
- Cervical smear: if due/overdue — defer to postnatal if possible
- Thyroid palpation if indicated
Booking Investigations
| Test | Purpose |
|---|
| FBC | Hb, platelets; anaemia detection |
| Blood group & Rh | ABO/Rh typing; antibody screen |
| Rubella serology | Immunity status (IgG) |
| Syphilis (VDRL/TPPA) | Treat if positive; reduce congenital syphilis |
| HIV (4th gen Ag/Ab) | PMTCT if positive |
| Hepatitis B surface Ag | Neonatal vaccination if carrier |
| Hepatitis C antibody | Maternal treatment, neonatal follow-up |
| Haemoglobinopathy screen | Sickle cell, thalassaemia — partner testing if carrier |
| Urine dipstick / MSU | Asymptomatic bacteriuria (treat if positive) |
| OGTT (75g) | High-risk: BMI>30/GDM history/macrosomia — at booking and 24–28w |
| Booking scan (USS) | 11–13+6 weeks: dating, viability, NT, chorionicity |
| Urine protein:creatinine ratio | If dipstick ≥1+ protein |
Risk Stratification
Low Risk
Medium Risk
High Risk
Low Risk Pathway
- Nulliparous or low parity, no medical/obstetric complications, singleton, uncomplicated pregnancy — midwife-led care, standard schedule
Medium Risk Pathway
- BMI 30–40, single previous CS, mild hypertension, gestational diabetes previous pregnancy, age >40, smoking — shared care, consultant review
High Risk Pathway
- Pre-existing diabetes/hypertension/cardiac/renal/autoimmune, previous stillbirth, multiple pregnancy, BMI >40, previous severe pre-eclampsia, placenta praevia — consultant-led with multidisciplinary input
Safeguarding & Mental Health Screening
Domestic Violence — HITS Tool
Ask at booking (alone, in preferred language): "How often does your partner: Hurt / Insult / Threaten / Scream at you?" Score >10 = positive screen → refer to safeguarding team, safety plan, document in records.
Always ask when woman is alone. Use professional interpreters — never family/partner.
Edinburgh Postnatal Depression Scale (EPDS) at Booking
- 10-item validated self-report scale — also validated for antenatal use
- Score ≥13: likely depression → refer to perinatal mental health team
- Question 10 (self-harm): score ≥1 → immediate psychiatric review
- Repeat at 28 weeks and postnatally at 6 weeks
Antenatal screening enables early identification of conditions affecting mother and/or fetus. Informed consent and non-directive counselling are essential before all screening tests.
First Trimester Combined Screening (11–13+6 weeks)
Components
- Nuchal Translucency (NT) measurement — USS measurement of fluid at fetal neck (normal <3.5 mm; abnormal ≥3.5 mm)
- Serum PAPP-A (pregnancy-associated plasma protein A) — low in trisomy 21
- Free β-hCG — elevated in trisomy 21, low in trisomy 18/13
- Maternal age-related risk calculation
- Combined risk ratio: Down's syndrome (T21) / Edwards (T18) / Patau (T13)
Result Interpretation
- High risk: ≥1:150 → offer diagnostic testing (CVS or amniocentesis)
- Intermediate: 1:151–1:1000 → discuss NIPT
- Low risk: <1:1000 — continue routine care
Pre-Eclampsia First Trimester Screening
- Uterine artery Doppler (UtA-PI)
- PLGF (placental growth factor) — low levels predict PE
- Mean arterial pressure (MAP)
- Combined with maternal factors + BMI → Fetal Medicine Foundation algorithm
- Detection rate ~75% for preterm PE, ~45% term PE
If HIGH RISK for pre-eclampsia: start Aspirin 150 mg nocte before 16 weeks (ideally 11–14 weeks) — continue until 36 weeks
Anomaly Scan — 18–20+6 Weeks
Structures Examined
- Head: cerebral ventricles, posterior fossa, choroid plexus, cavum septi pellucidi
- Face: lips (cleft lip screening), profile, orbits
- Spine: neural tube defects (spina bifida, anencephaly)
- Heart (4-chamber view + outflow tracts): CHD detection — VSD, AVSD, TGA, HLHS
- Abdomen: anterior abdominal wall (gastroschisis, exomphalos), stomach, bowel
- Kidneys: bilateral presence, renal pelvis dilatation (>7 mm = refer), bladder
- Limbs: long bones — femur length, skeletal dysplasia
- Placenta location: low-lying → plan follow-up scan at 32 weeks
- Cervical length: if history of preterm / prior LLETZ
Soft markers (echogenic foci, pyelectasis, EIF): counsel regarding risk modification — do not diagnose chromosomal anomaly alone.
NIPT — Non-Invasive Prenatal Testing
Cell-Free DNA (cfDNA)
- Analyses fetal DNA fragments in maternal blood
- Detects: Trisomy 21 (DR ~99%), Trisomy 18 (DR ~98%), Trisomy 13 (DR ~99%)
- Also: monosomy X (Turner), sex chromosome aneuploidies, microdeletions (22q11) — varies by panel
- Can be performed from 10 weeks
- Increasingly available in GCC private sector; not universally offered in government facilities
- Sensitivity >99%, but NOT diagnostic — positive results require confirmation (CVS/amnio)
- Failure rate ~2–3% (low fetal fraction: BMI>30, early gestation, heparin use)
When to Offer
- After screen-positive first trimester combined test
- Advanced maternal age (≥35)
- Parental request in private setting
- Previous trisomy pregnancy
Diagnostic Invasive Testing
| Procedure | Timing | Indication | Risk (miscarriage) |
|---|
| CVS (Chorionic Villus Sampling) | 11–14 weeks | Screen positive / high genetic risk | ~0.5–1% |
| Amniocentesis | ≥15 weeks | Screen positive / abnormal USS | ~0.5% |
- Both provide karyotype; microarray offers higher resolution (CNVs)
- Offered after screen-positive result with appropriate pre-test counselling
- Non-directive: respect patient autonomy and cultural/religious values
- Anti-D prophylaxis: required for Rh-negative women after procedure
GBS Screening & Intrapartum Prophylaxis
Group B Streptococcus
- Rectovaginal swab at 35–37 weeks in some GCC/hospital protocols
- Urine culture positive for GBS at any gestation: treat intrapartum
- Intrapartum antibiotic prophylaxis (IAP): Penicillin G IV during labour (Ampicillin if penicillin allergy)
- IAP indications: GBS positive culture, previous GBS-affected baby, GBS bacteriuria this pregnancy
- Risk factors: preterm labour <37w, ROM >18h, intrapartum fever >38°C
- Note: universal testing varies by GCC country — follow local protocol
Vigilant monitoring for obstetric complications reduces maternal and perinatal morbidity. Know your escalation pathway and escalate promptly.
Pre-Eclampsia Surveillance
Diagnosis Criteria
- BP ≥140/90 mmHg on 2 occasions ≥4h apart after 20 weeks
- PLUS proteinuria (≥300 mg/24h or PCR ≥30 mg/mmol) or target organ involvement
- Severe features: BP ≥160/110, headache, visual disturbance, RUQ/epigastric pain, HELLP (haemolysis, elevated liver enzymes, low platelets), AKI, pulmonary oedema
Monitoring Protocol
- BP 2–4 times per day if hospitalised
- Urine PCR or 24h urine collection
- FBC, U&E, LFTs, uric acid — twice weekly minimum
- Growth USS + umbilical artery Doppler every 2 weeks
- CTG 2–3x/week for FGR or severe PE
Management
- Antihypertensives: Labetalol PO/IV (first-line), Nifedipine, Methyldopa
- MgSO4: IV if severe PE — eclampsia prevention (loading 4g IV over 15 min, then 1g/h infusion) — monitor reflexes, UO, respiratory rate
- Delivery timing: ≥37w: deliver if mild-moderate PE; immediate if severe or any organ dysfunction
- Corticosteroids if <34 weeks (fetal lung maturation)
- Fluid restriction: max 80 ml/h (risk pulmonary oedema)
- Postpartum: continue antihypertensives, monitor for 5 days
IUGR / FGR (Fetal Growth Restriction)
- Estimated fetal weight (EFW) <10th centile and/or abdominal circumference <10th centile
- Causes: placental insufficiency, maternal hypertension/smoking, fetal chromosomal anomaly, infection (CMV, toxoplasmosis)
- Early FGR: <32 weeks — more severe, Doppler changes earlier
- Late FGR: ≥32 weeks — Doppler may be normal initially
Doppler Surveillance
- Umbilical artery (UA) PI: raised → absent end-diastolic flow → reversed flow (progressive deterioration)
- Middle cerebral artery (MCA): low PI = brain-sparing (poor prognosis)
- Ductus venosus (DV): reversed a-wave = immediate delivery consideration
- CPR (cerebroplacental ratio MCA/UA <1.0) = fetal compromise
- Growth scan every 2 weeks; CTG 2–3x/week with severe FGR
Amniotic Fluid Disorders
Polyhydramnios (AFI >25 cm)
- Causes: GDM (fetal polyuria), fetal anomaly (oesophageal atresia, NTD, CHD), idiopathic (50%)
- Symptoms: maternal breathlessness, discomfort, preterm labour risk
- Investigations: detailed anomaly scan, OGTT, TORCH serology
- Management: symptomatic amnioreduction if severe; treat GDM
Oligohydramnios (AFI <5 cm)
- Causes: placental insufficiency/FGR, fetal renal anomaly (renal agenesis, posterior urethral valves), ROM (ruptured membranes), post-dates
- Investigations: confirm membranes intact (pooling, ferning, PAMG-1 test), fetal anatomy scan, Doppler
- Severe oligohydramnios: urgent assessment, delivery consideration
Placenta Praevia Follow-Up
- Low-lying placenta at anomaly scan: repeat scan at 32 weeks
- Still low at 32w: repeat at 36 weeks
- Major placenta praevia (<20 mm from os): plan elective CS at 36–37 weeks
- Suspected placenta accreta spectrum (PAS): MRI, multidisciplinary planning, specialist centre delivery
- Advise: avoid intercourse, pelvic rest, hospitalise if bleeding
- Group and save at each hospital attendance
- Discuss risks: antepartum haemorrhage, PPH, hysterectomy risk
Multiple Pregnancy
Chorionicity Assessment (10–14 weeks)
- DCDA (dichorionic diamniotic): T-sign — 2 placentas or thick dividing membrane
- MCDA (monochorionic diamniotic): lambda sign — thin membrane
- MCMA (monochorionic monoamniotic): highest risk — NICU delivery planned
TTTS (Twin-to-Twin Transfusion Syndrome) — MCDA only
- Quinero staging I–V
- Surveillance: growth USS every 2 weeks from 16 weeks
- Treatment: fetoscopic laser ablation of anastomoses (specialist centre)
- DCDA: growth USS every 4 weeks from 20 weeks
- Delivery: DCDA 37–38w; MCDA 36–37w; MCMA 32–34w
Malpresentation — Unstable Lie
Breech Presentation
- Offer ECV (External Cephalic Version) at 36 weeks (nulliparous) or 37 weeks (multiparous)
- Success rate ~50%; higher in multiparous, normal AFI, non-engaged
- Contraindications: placenta praevia, multiple pregnancy, severe oligohydramnios, previous uterine scar (relative)
- If ECV fails/declined: counsel on planned CS vs vaginal breech birth
Unstable / Transverse Lie
- After 36 weeks: exclude placenta praevia, pelvic mass, uterine abnormality
- Grand multiparity: common cause in GCC
- Admit if unstable at 37–38 weeks; await for stabilisation
- Risk: cord prolapse with membrane rupture — emergency CS
Systematic fetal wellbeing assessment identifies at-risk fetuses before compromise becomes irreversible. Act on abnormal results promptly.
Fetal Kick Counting
Cardiff "Count to 10" Method
- Count from morning until 10 movements felt — should occur by midday
- Normal: 10 movements in 12 hours or fewer
- Concern: <10 movements in 12 hours OR absent movement → contact maternity unit immediately
- Start formal counting from 28 weeks
- Educate: any perceived reduction from normal pattern warrants assessment
- Do NOT use Doppler at home to reassure — attend hospital for CTG
- Reduced fetal movement: perform CTG + USS if indicated
- Repeated RFM: growth scan + Doppler
CTG Interpretation — NICE Classification
| Feature | Reassuring | Non-Reassuring | Abnormal |
|---|
| Baseline rate | 110–160 bpm | 100–109 or 161–180 | <100 or >180 |
| Variability | 5–25 bpm | <5 for 30–50 min | <5 for >50 min; sinusoidal |
| Accelerations | ≥2 in 20 min | None in 40 min | None in 80 min |
| Decelerations | None / early only | Variable decels | Late / prolonged |
- Normal CTG: all 4 features reassuring
- Suspicious CTG: 1 non-reassuring feature → review, consider further assessment
- Pathological CTG: 2+ non-reassuring OR 1+ abnormal → immediate review, consider delivery
- Scalp stimulation: acceleration rules out acidosis if present
Biophysical Profile (BPP)
Combines USS assessment + CTG. Each component scored 0 (absent) or 2 (present):
| Component | Normal (score 2) |
|---|
| Fetal Breathing Movements | ≥1 episode ≥30 sec in 30 min |
| Gross Body Movements | ≥3 body/limb movements in 30 min |
| Fetal Tone | ≥1 flexion/extension with return in 30 min |
| Amniotic Fluid Volume | Single deepest pocket ≥2 cm |
| CTG (non-stress test) | ≥2 accelerations in 20 min |
- 8–10: Normal — routine management
- 6: Equivocal — repeat in 24h; consider delivery if ≥36w
- 4: Abnormal — prompt delivery consideration
- 0–2: Deliver
Doppler Studies
Umbilical Artery (UA)
- Reflects placental resistance — high PI = placental insufficiency
- Absent end-diastolic flow (AEDF): severe FGR — plan delivery
- Reversed end-diastolic flow (REDF): critical — emergency delivery
Middle Cerebral Artery (MCA)
- Low MCA PI = vasodilation = brain-sparing response
- MCA PSV >1.5 MoM: fetal anaemia (Rh disease, hydrops) → consider IUT
Ductus Venosus (DV)
- Absent/reversed a-wave: severe cardiac compromise → deliver within 24–48h
Uterine Artery
- First trimester: high PI / notching → pre-eclampsia/FGR risk
Symphysis-Fundal Height (SFH) Measurement
Technique
- Measure from upper border of symphysis pubis to uterine fundus
- Use non-elastic tape measure; woman semi-recumbent, bladder emptied
- From 24 weeks onwards at every antenatal visit
- Plot on customised growth chart (GROW chart)
Expected Values
- SFH (cm) approximates gestational age in weeks (±2 cm)
- Flag: SFH <2 cm below gestational age in weeks → USS for growth assessment
- Consecutive small measurements crossing centiles: refer for growth USS
Interpretation Caveats
- Obese women: SFH less reliable — use serial USS for growth
- Fibroids may distort measurement
- Engagement of head at term may reduce SFH
- Polyhydramnios: SFH large for dates
- Always plot, never rely on single measurement alone
- Customised charts account for maternal height/weight/parity/ethnicity
Growth Centiles
- Customised charts (GROW) preferred over population charts
- EFW <10th centile on USS: FGR assessment pathway
- EFW >90th centile: macrosomia — GDM screen, watch for shoulder dystocia
Antenatal education reduces anxiety, improves birth outcomes, and supports informed decision-making. Tailor to individual needs, cultural background, and literacy level.
Birth Planning
- Discuss birth preferences from 28–30 weeks
- Explore: labour positions, pain relief preferences, birth partner
- Episiotomy / instrumental delivery information
- Immediate skin-to-skin contact, delayed cord clamping (30–60 sec)
- Infant feeding choice documentation
- Third stage management (active vs physiological)
- Cultural/religious considerations — female-only team in GCC
- Arabic birth plan templates available (see GCC Context tab)
- Review and update plan at 36-week appointment
VBAC Counselling
- VBAC success rate: ~72–75% if single lower segment CS
- Uterine rupture risk: ~0.5% (vs 0.02% repeat CS)
- Requirements: continuous EFM, IV access, theatre available
- Contraindications: previous classical incision, >2 previous CS (relative), placenta praevia, prior uterine rupture
Labour Pain Relief Options
- Non-pharmacological: breathing techniques, TENS, water (pool/shower), massage, mobilisation, acupressure
- Entonox (50% N2O/O2): inhaled, self-administered, rapid onset/offset
- Opioids: Pethidine/Diamorphine IM — neonatal respiratory depression risk; Naloxone available
- Epidural: most effective; discuss timing (can have at any cervical dilation), hypotension risk, reduced urge to push, catheter required, longer 2nd stage
- CSE (combined spinal-epidural): faster onset, good for late labour
- Remifentanil PCA: effective IV opioid, specialist monitoring required
Perineal Massage
- Start from 32–34 weeks, 1–2x/week
- Reduces risk of 3rd/4th degree tears and episiotomy in nulliparous
- Technique: thumb insert 3–4 cm, downward pressure 2 min, circular massage
Infant Feeding & Newborn Education
Breastfeeding Promotion
- WHO: exclusive breastfeeding 6 months
- Benefits: maternal (oxytocin/uterine involution, reduced ovarian/breast cancer risk) and infant (immunity, gut microbiome, reduced obesity/T2DM/SIDS)
- Discuss latch technique, feeding frequency (8–12x/24h newborn), signs of adequate intake
- Breast engorgement, nipple pain — early support key
- Support: lactation consultant, peer support groups
Safe Sleep (SIDS Prevention)
- Back to sleep, every sleep
- Firm flat surface, no loose bedding
- Room temperature 16–20°C; no bed-sharing if smoking/alcohol/drugs
- Do not overbundle
Newborn Care
- Umbilical cord: keep dry and clean; clamp falls off 7–10 days
- Bathing: sponge bath until cord stump separates; warm water only
- Vaccination schedule: Hep B at birth (especially GCC), BCG, standard schedule
- Newborn screening (heel-prick): PKU, hypothyroidism, haemoglobinopathies, metabolic disorders
Warning Signs — When to Seek URGENT Help
Go to hospital IMMEDIATELY if you experience any of the following:
- Reduced or absent fetal movements
- Vaginal bleeding (any amount after 20 weeks)
- Fluid loss per vaginum (membranes may have ruptured)
- Severe headache not relieved by paracetamol
- Visual disturbances (blurring, flashing lights, spots)
- Right upper quadrant / epigastric pain
- Sudden severe oedema (face, hands, feet)
- Fever >38°C or signs of infection
- Painful contractions before 37 weeks
- Thoughts of self-harm
Caesarean Section Preparation
Pre-operative Education
- Fasting instructions: 6h solid food, 2h clear fluids before planned CS
- Discuss: spinal/epidural anaesthesia, unlikely to feel pain (pressure sensation normal)
- Skin-to-skin in theatre when possible (if stable)
- Surgical prep: pre-op blood test, consent form, VTE prophylaxis
- Compression stockings + LMWH postoperatively
Recovery Expectations
- Hospital stay: 2–4 days
- Wound care: dry dressing, check at 5 days
- Lifting restriction: avoid lifting >baby weight for 6 weeks
- Driving: not for 6 weeks (or until can perform emergency stop)
- Pain management: regular paracetamol/ibuprofen +/- opioids
- Scar: red herring uterine pain ("itch") common 6–8 weeks
GCC antenatal care has unique cultural, demographic, and epidemiological characteristics. Culturally sensitive, woman-centred care is essential for engagement and safety.
Late Booking — GCC Challenges
- Cultural factors: preference to confirm pregnancy after first trimester; family consultation before seeking care
- Multiple employment / working long hours (expatriate population)
- Limited knowledge of antenatal screening benefits
- Language barriers (Arabic, Urdu, South Asian languages dominant in GCC)
- Fear of disclosure or stigma
Nursing Approach
- Non-judgmental approach; accelerated booking protocol
- Offer interpreter services — never use family member/partner
- Community outreach and health education in multiple languages
- Provide written information in Arabic and other prevalent languages
Grand Multiparity in GCC
- Defined as ≥5 previous deliveries; higher prevalence in GCC due to cultural/religious norms
- Increased risks:
- Postpartum haemorrhage (uterine atony)
- Uterine rupture (especially with previous scar)
- Placenta praevia and placenta accreta spectrum
- Malpresentation (unstable lie / transverse)
- Anaemia (iron depletion from repeated pregnancies)
- Gestational diabetes
- Management: consultant-led care, group and save at each visit from 28 weeks, active management of 3rd stage, early IV access in labour, USS placenta location
Consanguinity
- First-cousin marriages: 25–60% in some GCC populations (highest globally)
- Increases risk of: autosomal recessive disorders, structural malformations, chromosomal anomalies
- Nursing approach:
- Detailed family pedigree at booking
- Offer detailed anomaly scan (including fetal echo if indicated)
- Discuss NIPT and diagnostic testing — with genetic counselling
- Refer to clinical genetics if family history of specific condition
- Non-directive, culturally sensitive counselling — consanguinity is culturally normalised; do not stigmatise
Haemoglobinopathy Screening
- Mandatory premarital testing in Saudi Arabia, Qatar, UAE, Bahrain — sickle cell and thalassaemia
- Sickle cell disease: prevalent in Arab, African, South Asian populations
- Beta-thalassaemia: prevalent in Arab, Mediterranean, South Asian populations
- If both partners carriers: 25% risk of affected child → offer PND (CVS/amniocentesis) or PGT (pre-implantation genetic testing)
- Sickle cell in pregnancy: increased risk of crises (hydroxyurea contraindicated in pregnancy), PE, FGR, preterm labour → haematology co-management
- Thalassaemia major: usually managed with transfusion — chelation agents (Desferrioxamine, Deferiprone) — review medications in pregnancy
Ramadan in Pregnancy
- Many Muslim women wish to fast during Ramadan regardless of gestation
- First trimester: nausea/vomiting + fasting = increased dehydration risk, hyperemesis risk, reduced early nutrition
- Islamic ruling: pregnant and breastfeeding women are exempted from fasting — most scholars agree they may make up fasts later or pay fidya (compensation); advise sensitively
- Evidence: fasting associated with low birth weight, preterm birth in some studies — particularly early pregnancy
- If woman chooses to fast: ensure adequate suhoor (pre-dawn meal), hydration at night, avoid strenuous activity, monitor fetal movements daily, attend if unwell
- Discuss medication timing (e.g., iron, folic acid, metformin) — can be adjusted to iftar/suhoor
- Diabetic pregnant women: do NOT fast — severe hypoglycaemia risk
Vitamin D Deficiency in GCC
- Paradox: sunny region, yet high rates of deficiency (50–80% in some GCC populations)
- Risk factors: indoor lifestyle (air-conditioning culture), full covering (abaya/niqab), high melanin skin, avoidance of sun exposure
- Consequences in pregnancy: neonatal hypocalcaemia, rickets, impaired immune function, increased risk of pre-eclampsia, gestational diabetes
- GCC practice: Universal supplementation — Vitamin D 10 mcg (400 IU) daily throughout pregnancy (higher doses — 1000–2000 IU — may be used if deficient; check local protocol)
- Check serum 25-OH Vitamin D at booking; supplement and recheck at 28 weeks if deficient
GCC Health System & Maternity Context
Maternal Mortality
- GCC maternal mortality ratios: among the lowest globally (UAE ~3/100,000; Saudi ~17/100,000; compared to global average ~211/100,000)
- Main causes remain: haemorrhage, hypertensive disorders, sepsis, thromboembolism
High CS Rates
- GCC CS rates: 30–50%+ in many centres (well above WHO 10–15% recommendation)
- Drivers: cultural preference, litigation fears, private sector incentives, lack of VBAC programmes
- Promote: VBAC programmes, normal birth culture, midwifery-led care where possible
Private vs Government Antenatal Care
- Government: free for citizens, subsidised for residents; structured pathways, multidisciplinary teams, evidence-based protocols; may have language/cultural barriers
- Private: more appointments, NIPT widely available, individual consultant relationships, continuity preferred; may lead to over-medicalisation, higher intervention rates
- Nursing role: advocate for evidence-based care regardless of sector
Female-Only Care & Cultural Considerations
- Female-only care preference: strongly prevalent in GCC — particularly for pelvic/obstetric examinations
- Ensure female doctor/midwife for intimate examinations whenever possible and documented in care plan
- Male healthcare workers: formal consent and chaperone mandatory
- Birth partner: husband/female relative — vary by family; always ask preference
- Privacy and dignity: essential — closed curtains, appropriate gowns, no unnecessary exposure
- Language: always offer professional interpreter; avoid children or male relatives as interpreters
- Dietary restrictions: halal food in hospital, Ramadan awareness
- Prayer facilities: accommodate prayer times in hospital scheduling where possible
Arabic Birth Plan Templates
- Offer Arabic language birth plan forms
- Key sections: pain relief preferences, labour companion, delivery position, cord cutting, infant feeding, postpartum rest preferences, blood transfusion consent (if objection on religious grounds — document clearly and escalate)